Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder - 2Firefighters rescue two Israelis trapped in vehicles on flooded roads in West Bank
- 3What loving-kindness meditation is and how to practice it in the new year
- 4Beyond the habitable zone: Exoplanet atmospheres are the next clue to finding life on planets orbiting distant stars
- 5Drones haven't won the fight in Ukraine. That matters as the West learns new ways of war.
- The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies
- Nodding off is dangerous. Some animals have evolved extreme ways to sleep in precarious environments
- Instructions to Pick the Right Toothbrush for Your Teeth
- Lily Allen 2026 'West End Girl' arena tour: How to get tickets, prices and more
- CVS forecasts 2026 profit above estimates on strong performance
- The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise...
- 2 bright planets light up April evenings — here's where and when to look
- Insane Realities That Will Make You Reconsider How you might interpret History
- SpaceX's 1st 'Version 3' Super Heavy Starship booster buckles under pressure during initial tests
